{
 "awd_id": "0418244",
 "agcy_id": "NSF",
 "tran_type": "Grant",
 "awd_istr_txt": "Standard Grant",
 "awd_titl_txt": "SBIR Phase I:     Environmental Neurotoxicity Using Zebrafish",
 "cfda_num": "47.084",
 "org_code": "15030000",
 "po_phone": null,
 "po_email": "",
 "po_sign_block_name": "George B. Vermont",
 "awd_eff_date": "2004-07-01",
 "awd_exp_date": "2005-06-30",
 "tot_intn_awd_amt": 100000.0,
 "awd_amount": 100000.0,
 "awd_min_amd_letter_date": "2004-05-24",
 "awd_max_amd_letter_date": "2004-11-04",
 "awd_abstract_narration": "This Small Business Innovation Research (SBIR) Phase I project proposes to develop and validate zebrafish assays for testing of industrial chemicals for developmental neurotoxicity with reduced cost and shorter turn around times compared with available methods. \r\n\r\nThe commercial application of this project will be in the area of environmental toxicology. The impact of neurotoxins on the development of fetuses and children has been established for a few contaminants such as lead, but remains largely unexplored for most contaminants. Therefore, the development of a proven animal model will be both scientifically and commercially useful.\r\n",
 "awd_arra_amount": 0.0,
 "dir_abbr": "TIP",
 "org_dir_long_name": "Directorate for Technology, Innovation, and Partnerships",
 "div_abbr": "TI",
 "org_div_long_name": "Translational Impacts",
 "awd_agcy_code": "4900",
 "fund_agcy_code": "4900",
 "pi": [
  {
   "pi_role": "Principal Investigator",
   "pi_first_name": "Catherine",
   "pi_last_name": "Willett",
   "pi_mid_init": "E",
   "pi_sufx_name": "",
   "pi_full_name": "Catherine E Willett",
   "pi_email_addr": "kptnkate@phylonix.com",
   "nsf_id": "000480055",
   "pi_start_date": "2004-05-24",
   "pi_end_date": null
  }
 ],
 "inst": {
  "inst_name": "PHYLONIX PHARMACEUTICAL INC",
  "inst_street_address": "100 INMAN ST STE 300",
  "inst_street_address_2": "",
  "inst_city_name": "CAMBRIDGE",
  "inst_state_code": "MA",
  "inst_state_name": "Massachusetts",
  "inst_phone_num": "6174416700",
  "inst_zip_code": "021399129",
  "inst_country_name": "United States",
  "cong_dist_code": "07",
  "st_cong_dist_code": "MA07",
  "org_lgl_bus_name": null,
  "org_prnt_uei_num": null,
  "org_uei_num": null
 },
 "perf_inst": {
  "perf_inst_name": "PHYLONIX PHARMACEUTICAL INC",
  "perf_str_addr": "100 INMAN ST STE 300",
  "perf_city_name": "CAMBRIDGE",
  "perf_st_code": "MA",
  "perf_st_name": "Massachusetts",
  "perf_zip_code": "021399129",
  "perf_ctry_code": "US",
  "perf_cong_dist": "07",
  "perf_st_cong_dist": "MA07",
  "perf_ctry_name": "",
  "perf_ctry_flag": "1"
 },
 "pgm_ele": [
  {
   "pgm_ele_code": "537100",
   "pgm_ele_name": "SBIR Phase I"
  }
 ],
 "pgm_ref": [
  {
   "pgm_ref_code": "9104",
   "pgm_ref_txt": "ENVIRONMENTAL BIOTECHNOLOGY"
  },
  {
   "pgm_ref_code": "BIOT",
   "pgm_ref_txt": "BIOTECHNOLOGY"
  }
 ],
 "app_fund": [
  {
   "app_code": "0104",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "490100",
   "fund_code": "app-0104",
   "fund_name": "",
   "fund_symb_id": ""
  }
 ],
 "oblg_fy": [
  {
   "fund_oblg_fiscal_yr": 2004,
   "fund_oblg_amt": 100000.0
  }
 ],
 "por": null
}